Skip to search formSkip to main contentSkip to account menu

CB 30865

Known as: CB-30865, CB30865 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Quinazolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Previews NAD as a Genotype-Specific Drug Target
Philadelphia chromosome-positive chronic myelogenous leukemia remains the paragon of genotype-targeted cancer pharmacology. The… 
2010
2010
Abstract 3673: Identifying the target of an orphan compound: CB30865 is a Nampt inhibitor
Background: Drug discovery based on cellular phenotypes is impeded by the challenge of identifying the molecular target. To… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)